Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search:
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"CADTH Canadian Drug Expert Committee"
Showing
141
-
160
of
214
Search:
''
,
query time: 0.02s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
141
CDEC final recommendation: Tiotropium bromide (Spiriva respimat -- Boehringer Ingelheim Canada Ltd.) : indication : chronic obstructive pulmonary disease
Published 2015
Canadian Agency for Drugs and Technologies in Health
Read Now
142
CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus -- Hoffmann-La Roche Limited) : indication : treatment of adult patients with relapsing-remitting multiple...
Published 2017
Canadian Agency for Drugs and Technologies in Health
Read Now
143
CADTH Canadian Drug Expert Committee recommendation: AbobotulinumtoxinA (Dysport therapeutic -- Ipsen Biopharmaceuticals Canada Inc.) : indication: for the symptomatic treatment of...
Published 2017
Canadian Agency for Drugs and Technologies in Health
Read Now
144
CADTH Canadian Drug Expert Committee recommendation: Levodopa/carbidopa intestinal gel (Duodopa -- Abbvie Corporation) : indication : Parkinson's disease
Published 2018
Canadian Agency for Drugs and Technologies in Health
Read Now
145
CADTH Canadian Drug Expert Committee recommendation: Insulin degludec and liraglutide (Xultophy -- Novo Nordisk Canada Inc.) : indication : adjunct to lifestyle modifications, for...
Published 2019
CADTH
Read Now
146
CADTH Canadian Drug Expert Committee recommendation: Latanoprostene bunod (Vyzulta -- Bausch Health, Canada Inc.) : indication : for the reduction of intraocular pressure (IOP) in...
Published 2019
Canadian Agency for Drugs and Technologies in Health
Read Now
147
CADTH Canadian Drug Expert Committee final recommendation: Tiotropium/Olodaterol (Inspiolto Respimat - Boehringer Ingelheim Canada Ltd.) indication : chronic obstructive pulmonary...
Published 2015
Canadian Agency for Drugs and Technologies in Health
Read Now
148
Optimal use of minimally invasive glaucoma surgery: Recommendations
Published 2019
Canadian Agency for Drugs and Technologies in Health
Read Now
149
CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin (Steglatro -- Merck Canada Inc.) : indication : diabetes mellitus, type 2
Published 2019
CADTH
Read Now
150
CADTH Canadian Drug Expert Committee recommendation: Cerliponase Alfa (Brineura -- Biomarin Pharmaceutical [Canada] Inc.) : indication : for the treatment of neuronal ceroid lipofu...
Published 2019
CADTH
Read Now
151
CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin/Metformin (Segluromet -- Merck Canada Inc.) : indication : diabetes mellitus, type 2
Published 2019
CADTH
Read Now
152
CADTH Canadian Drug Expert Committee recommendation: Guselkumab (Tremfya -- Janssen Inc.) : indication : for the treatment of adult patients with moderate-to-severe plaque psoriasi...
Published 2018
CADTH
Read Now
153
CADTH Canadian Drug Expert Committee final recommendation: Mifepristone and misoprostol (Mifegymiso -- Celopharma Inc.) : indication: medical termination of pregnancy
Published 2017
Canadian Agency for Drugs and Technologies in Health
Read Now
154
CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: ankylosing spondylitis
Published 2020
CADTH
Read Now
155
CADTH Canadian Drug Expert Committee recommendation: Onasemnogene abeparvovec (Zolgensma -- Novartis Pharmaceuticals Canada Inc.) : indication: spinal muscular atrophy
Published 2021
Canadian Agency for Drugs and Technologies in Health
Read Now
156
CADTH Canadian Drug Expert Committee recommendation: Ranolazine (Corzyna -- KYE pharmaceuticals Inc.) : indication: patients with stable angina pectoris who are inadequately contro...
Published 2021
Canadian Agency for Drugs and Technologies in Health
Read Now
157
CADTH Canadian Drug Expert Committee recommendation: Ofatumumab (Kesimpta -- Novartis Hharmaceuticals Canada Inc.) : indication : multiple sclerosis, relapsing-remitting
Published 2021
Canadian Agency for Drugs and Technologies in Health
Read Now
158
CADTH Canadian Drug Expert Committee recommendation: Apomorphine hydrochloride (Kynmobi -- Sunovion Pharmaceuticals Canada inc.) : indication : the acute, intermittent treatment of...
Published 2021
Canadian Agency for Drugs and Technologies in Health
Read Now
159
CADTH Canadian Drug Expert Committee recommendation: Icosapent ethyl (Vascepa -- HLS Therapeutics Inc.) : indication : prevention of cardiovascular events in statin-treated patient...
Published 2020
Canadian Agency for Drugs and Technologies in Health
Read Now
160
CADTH Canadian drug expert committee recommendation: Burosumab (Crysvita -- Kyowa Kirin Limited) : indication : treatment of x-linked hypophosphatemia
Published 2020
Canadian Agency for Drugs and Technologies in Health
1
2
3
4
5
6
7
8
9
10
11
Back
Narrow Search
Remove Filters
Clear Filter
Author: CADTH Canadian Drug Expert Committee
Year of Publication
From:
To:
Classification
610 - Medicine & health
201
330 - Economics
113
140 - Specific philosophical schools
24
700 - The arts; fine & decorative arts
17
580 - Plants (Botany)
3
800 - Literature & rhetoric
2
more ...
380 - Commerce, communications & transportation
1
see all ...
less ...
Language
English
214
Collection
National Center for Biotechnology Information
214
Author
CADTH Canadian Drug Expert Committee
Canadian Agency for Drugs and Technologies in Health
161
Recently Uploaded
Last Month
10
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?page=8&filter%5B%5D=author_facet%3A%22CADTH+Canadian+Drug+Expert+Committee%22&type=AllFields
Send by Email
×
Loading...